Newsletter Subject

Conservative Oxygenation Outperforms Liberal Targets for Critically Ill Kids

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Tue, Dec 5, 2023 11:52 PM

Email Preheader Text

Daily Headlines Tuesday, December 05, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIG

[MEDPAGE TODAY]( Daily Headlines Tuesday, December 05, 2023 Today's Top Stories for {NAME} [CRITICAL CARE]( [Conservative Oxygenation Outperforms Liberal Targets for Critically Ill Kids]( [OPINION]( [Pursuing My Passions: Why I Didn't Do Residency After Medical School]( [NEUROLOGY]( [Alzheimer's Blood Test Predicts Who Might Benefit Most From Anti-Amyloid Drugs]( THE BREAK ROOM [Spell Check-Up: Try to Pass This Spelling Quiz]( CME SPOTLIGHT [Applying the Latest Clinical Evidence to Treatment Plans for Pediatric Patients With Hodgkin Lymphoma]( [NEPHROLOGY]( [Quick Albuminuria Reduction Key Factor in Finerenone's Efficacy]( [CARDIOLOGY]( [Win for Vegan Diet; Injectable Balloon Catheters OK'd; OAC Options After Failed DOAC]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [MEETING COVERAGE]( [Novel Doublet Highly Effective in Low-Grade Serous Ovarian Cancer]( CME SPOTLIGHT [CAR T-Cell Therapy 101]( [NEUROLOGY]( [Personality Predictors of Dementia; Parkinson's Blood Test; Klotho in Alzheimer's]( [MEETING COVERAGE]( [TULSA Effective in Controlling Prostate Cancer Long-Term]( [SPECIAL REPORTS]( [See Which States Have the Most High-Performing Hospitals for Maternity Care]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Optimizing Anemia Management in Patients With Myelodysplastic Syndrome, Myelofibrosis, and Beta Thalassemia Through Shared Decision-Making]( [SPOTLIGHT ON]( [Patient-Centered Treatment in Generalized Myasthenia Gravis]( [MEETING COVERAGE]( [Cost Hurdles Can Keep Patients From Accessing GLP-1 Receptor Agonists]( [OPINION]( [How Much Pain Is 'Enough' to Prescribe Opioids?]( CME SPOTLIGHT [Applying the Latest Evidence for Anemia Management in Patients With Lower-Risk Myelodysplastic Syndrome, Myelofibrosis, and Beta Thalassemia]( [MEETING COVERAGE]( [Deucravacitinib Improves Joint Symptoms in Psoriatic Arthritis]( [OB/GYN]( [Serial Amnioinfusions Helped Neonates Survive Without Kidneys]( [PEDIATRICS]( [Early Surgery for Kids' Mild Sleep Apnea Doesn't Boost Executive Function]( CME SPOTLIGHT [Expanding Access to Novel Treatment Approaches for Multiple Myeloma]( [SPECIAL REPORTS]( [RaDonda Vaught Loses Appeal to Get Her Nursing License Back]( [ONCOLOGY/HEMATOLOGY]( [Rituximab Maintenance Boosts Survival for Older Adults With MRD-Negative MCL]( [ASCO READING ROOM]( [Dario Trapani, MD, on the Age Cap for OncotypeDX Testing Reimbursement]( CME SPOTLIGHT [Advancing cTTP Care Through Integration of the Latest Clinical Evidence]( [MEETING COVERAGE]( [Pharmacists Can Spur Switch to Recommended Drugs for Diabetes Patients With CVD]( # Weekly Survey [Concerned About China's Latest Outbreak?]( Chinese health officials have confirmed an [uptick in respiratory illness]( there, which they attribute to post-lockdown 'immunity debt.'[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-12-05&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.